Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Multivariate analysis of DFS and OS according to clinical pathological variables

From: Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases

Variables DFS OS
HR 95 % CL P-value HR 95 % CL P-value
Age (years) ≤50 vs. >50 0.786 0.404-1.527 0.477 0.698 0.340-1.432 0.327
Tumor size (cm)a ≤2 vs. >2, ≤5 vs. >5 1.283 0.721-2.281 0.397 1.405 0.760-2.598 0.279
Lymph node stage negative vs. positive 2.167 0.980-4.796 0.056 2.001 0.864-4.637 0.106
Grade G1 vs. G2 vs. G3 1.286 0.756-2.186 0.353 1.273 0.722-2.246 0.404
Histological type IDC vs. ILC vs. Others 0.742 0.422-1.306 0.301 0.651 0.345-1.228 0.185
Combined grouping others vs. PELP1, Ki-67 double high 2.020 1.022-3.990 0.043 2.380 1.138-4.978 0.021
  1. Abbreviations: LN, lymph node; DFS, disease-free survival; OS, overall survival; HR, hazard ratio; 95 % CL, 95 % confidence interval
  2. Note: afor the variable, data for two cases are unavailable from medical records
Back to article page